|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/12 | |
| C12N 15/62 | |||
| C07K 14/71 | |||
| A61K 38/17 |
| (11) | Number of the document | 2318529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09791148.1 |
| Date of filing the European patent application | 2009-08-04 | |
| (97) | Date of publication of the European application | 2011-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/052704 |
| Date | 2009-08-04 |
| (87) | Number | WO 2010/017198 |
| Date | 2010-02-11 |
| (30) | Number | Date | Country code |
| 86121 P | 2008-08-04 | US |
| (72) |
MARSHALL, Shannon, US
CHARYCH, Deborah, H., US
SADRA, Ali, US
|
| (73) |
Five Prime Therapeutics, Inc.,
Two Corporate Drive, South San Francisco, CA 94080,
US
|
| (54) | FGFR EXTRACELLULAR DOMAIN ACIDIC REGION MUTEINS |
| FGFR EXTRACELLULAR DOMAIN ACIDIC REGION MUTEINS |